SDI (SDI) Scheme meeting 2026 summary
Event summary combining transcript, slides, and related documents.
Scheme meeting 2026 summary
22 Jun, 2026Opening remarks and agenda
Meeting opened with a quorum present and introductions of the Board and key advisors, including legal and financial representatives.
Procedural and technical details for virtual participation and voting were explained, with instructions for shareholders on how to vote and submit questions.
The meeting's primary purpose was to consider and vote on a Scheme of arrangement for the acquisition of all shares.
Board and executive committee updates
Board members and executive team were introduced, including the Managing Director, COO, and Non-Executive Directors.
All Directors confirmed their intention to vote in favor of the Scheme and recommended shareholders do the same.
Non-Executive Directors received no exertion payments for work on the deal and will resign upon completion of the transaction.
Shareholder proposals
Shareholders raised questions about the choice of court jurisdiction, director payments, shareholder turnout, and the format of the meeting.
The Board addressed concerns about the lack of a hybrid AGM and explained the constitution was amended pre-COVID to allow virtual meetings.
Latest events from SDI
- Revenue up 2.7%, NPAT down 15.2%, with strong Aesthetics growth and acquisition talks ongoing.SDI
H1 2026 - Solid profit, strategic focus on aesthetics, and board stability highlighted amid market challenges.SDI
AGM 2025 - Gross margin rose to 62.9% as automation and new products offset flat sales and falling amalgam.SDI
H2 2025 - Record profit, strong product launches, and major manufacturing upgrades drive future growth.SDI
AGM 2024 - Record profit and margin growth led by Aesthetics, with automation and site expansion fueling outlook.SDI
H2 2024 - Net profit up 3.5% to AUD 3.8m as margin gains and Aesthetics growth offset regional declines.SDI
H1 2025